GlassScriptPhysician profile
Edmond J Ducommun
NPI 1093767816
$1,000.92
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $887 · 2020: $77.30 · 2022: $15.42 · 2023: $21.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $149.74 | 2019 | |
| Merck Sharp & Dohme LLC | $145.51 | 2019 | |
| Lilly USA, LLC | $140.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $129.28 | 2019 | |
| Novo Nordisk INC | $82.05 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $57.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $56.78 | 2019 | |
| Shire North American Group INC | $55.85 | 2019 | |
| Abbvie INC. | $36.60 | 2022-2023 | Viberzi, Linzess |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.39 | 2019-2020 | |
| Pfizer INC. | $23.04 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.51 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.35 | 2019 | |
| Melinta Therapeutics, LLC | $15.40 | 2019 | |
| Amgen INC. | $13.13 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $12.20 | 2020 | |
| Allergan, INC. | $11.66 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edmond Ducommun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.